Opportunity Information: Apply for PAR 25 043
The National Cancer Institute (NCI), part of the National Institutes of Health (NIH), is soliciting investigator-initiated research applications under the R01 mechanism through the funding opportunity titled "Mechanisms that Impact Cancer Risk after Bariatric Surgery (R01 Clinical Trial Optional)" (PAR-25-043). The central aim is to support studies that move beyond the typical short-term bariatric surgery endpoints like weight loss and diabetes control, and instead focus on understanding the biological, behavioral, and clinical mechanisms through which bariatric surgery may change a persons risk of developing cancer. In other words, NCI is trying to attract bariatric surgery researchers and related experts to pursue cancer-focused questions, especially mechanistic work that can explain why cancer risk appears to shift after surgery and for whom those effects are most relevant.
This opportunity is categorized as a discretionary grant program in the health and education domain, using the NIH R01 Funding Instrument. The "Clinical Trial Optional" designation means applicants may propose studies that include clinical trials if appropriate, but a clinical trial is not required. The NOFO is designed to fund rigorous, hypothesis-driven research that can clarify pathways linking bariatric procedures to downstream cancer-related outcomes, potentially including (as examples of the types of mechanism-oriented themes NCI typically seeks in such initiatives) changes in metabolism, inflammation, immune function, hormones, bile acids, the gut microbiome, nutrient sensing, adipose biology, or other systemic changes that plausibly influence carcinogenesis, tumor promotion, or cancer progression. The emphasis is on understanding causal or explanatory mechanisms rather than simply documenting associations.
Eligibility is broad and includes many types of domestic U.S. organizations and governments. Eligible applicants listed include state, county, and local governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; Native American tribal organizations that are not federally recognized; public housing authorities and Indian housing authorities; nonprofit organizations with or without 501(c)(3) status (other than institutions of higher education); for-profit organizations (other than small businesses); and small businesses. The announcement also explicitly highlights additional eligible applicant categories such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISI), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, eligible federal agencies, regional organizations, tribal governments other than federally recognized entities, and U.S. territories or possessions.
At the same time, there are important restrictions related to foreign participation. Non-domestic (non-U.S.) entities (foreign organizations) are not eligible to apply, and non-domestic components of U.S. organizations are not eligible to apply. However, foreign components, as defined in the NIH Grants Policy Statement, are allowed, meaning a U.S.-based applicant organization can include certain international elements or collaborations if they meet NIH policy requirements, even though a foreign organization cannot be the applicant institution itself.
Key administrative details included in the source information are that the opportunity is associated with CFDA numbers 93.393, 93.396, and 93.399, and it was created on 2024-09-05. The original closing date listed is 2028-01-07, indicating a multi-year window during which applications may be accepted according to the NOFOs submission schedule. The award ceiling shown is 500,000, which typically reflects a cap or a referenced upper bound in the summarized listing (applicants would still need to follow the detailed budget and project period rules described in the full NOFO and NIH policy). The expected number of awards is not specified in the provided data.
Overall, this NOFO is essentially a targeted call from NCI to build the evidence base on how bariatric surgery influences cancer risk by funding mechanistic, cancer-relevant research using the R01 framework. It encourages proposals that can explain underlying pathways, identify which patient subgroups may experience altered cancer risk, and generate insights that could shape future cancer prevention strategies, post-surgical surveillance approaches, or mechanistically informed interventions in populations undergoing bariatric procedures.Apply for PAR 25 043
- The National Institutes of Health in the education, health sector is offering a public funding opportunity titled "Mechanisms that Impact Cancer Risk after Bariatric Surgery (R01 Clinical Trial Optional)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.393, 93.396, 93.399.
- This funding opportunity was created on 2024-09-05.
- Applicants must submit their applications by 2028-01-07.
- Each selected applicant is eligible to receive up to $500,000.00 in funding.
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Browse more opportunities from the same category: Education, Health
Next opportunity: Towards a Better Understanding of the Neurological Effects of Infection-Associated Chronic Illnesses (R01 - Clinical Trial Optional)
Previous opportunity: NCI Research Specialist (Clinician Scientist) Award (R50 Clinical Trial Not Allowed)
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PAR 25 043
Applicants also applied for:
Applicants who have applied for this opportunity (PAR 25 043) also looked into and applied for these:
| Funding Opportunity |
|---|
| Mechanisms that Impact Cancer Risk after Bariatric Surgery (R21 Clinical Trial Not Allowed) Apply for PAR 25 044 Funding Number: PAR 25 044 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Basic Research in Cancer Health Disparities (R01 Clinical Trial Not Allowed) Apply for PAR 24 277 Funding Number: PAR 24 277 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Basic Research in Cancer Health Disparities (R21 Clinical Trial Not Allowed) Apply for PAR 24 291 Funding Number: PAR 24 291 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Exploratory Studies to Investigate Mechanisms of HIV infection, Replication, Latency, and/or Pathogenesis in the Context of Substance Use Disorders (R01 Clinical Trial Not Allowed) Apply for RFA DA 25 073 Funding Number: RFA DA 25 073 Agency: National Institutes of Health Category: Education, Health Funding Amount: $700,000 |
| Imaging - Science Track Award for Research Transition (I/START) (R03 Clinical Trial Optional) Apply for PAR 24 297 Funding Number: PAR 24 297 Agency: National Institutes of Health Category: Education, Health Funding Amount: $150,000 |
| Mechanism for Time-Sensitive Substance Use Research (R21 Clinical Trial Optional) Apply for PAR 24 298 Funding Number: PAR 24 298 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Behavioral and Integrative Treatment Development Program (R01 Clinical Trial Optional) Apply for PAR 24 299 Funding Number: PAR 24 299 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Advancing Health Equity through Interventions to Prevent and Address Housing Instability (R01 Clinical Trial Optional) Apply for RFA NR 25 001 Funding Number: RFA NR 25 001 Agency: National Institutes of Health Category: Education, Health Funding Amount: $500,000 |
| Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development of Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional) Apply for PAR 25 051 Funding Number: PAR 25 051 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Cancer Immunoprevention Network (CIP-Net) Resource Coordinating Center (U24 Clinical Trials Not Allowed) Apply for RFA CA 24 036 Funding Number: RFA CA 24 036 Agency: National Institutes of Health Category: Education, Health Funding Amount: $499,999 |
| Mitochondrial-associated Mechanisms of Neuropathological and Immunodeficient Aging in the Context of HIV and SUD (R21 Clinical Trials Not Allowed) Apply for RFA DA 26 010 Funding Number: RFA DA 26 010 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Mitochondrial-associated Mechanisms of Neuropathological and Immunodeficient Aging in the Context of HIV and SUD (R01 Clinical Trials Not Allowed) Apply for RFA DA 26 009 Funding Number: RFA DA 26 009 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Discovery and Development of Natural Products for Cancer Interception and Prevention (UG3/UH3 Clinical Trial Not Allowed) Apply for RFA CA 25 013 Funding Number: RFA CA 25 013 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed) Apply for PA 25 080 Funding Number: PA 25 080 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Scaling-up and Maintaining Evidence-based Interventions to Maximize Impact on Cancer (SUMMIT) - Tobacco Use Treatment for Cancer Survivors (UG3/UH3 Clinical Trial Required) Apply for RFA CA 25 010 Funding Number: RFA CA 25 010 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Scaling-up and Maintaining Evidence-based Interventions to Maximize Impact on Cancer (SUMMIT)- Lung Cancer Screening (UG3/UH3 Clinical Trial Required) Apply for RFA CA 25 009 Funding Number: RFA CA 25 009 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Limited Competition: NCI National Clinical Trials Network - Network Group Statistics and Data Management Centers (U10 Clinical Trial Required) Apply for RFA CA 24 031 Funding Number: RFA CA 24 031 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| NCI National Clinical Trials Network - Network Group Integrated Translational Science Centers (UG1 Clinical Trial Not Allowed) Apply for RFA CA 24 035 Funding Number: RFA CA 24 035 Agency: National Institutes of Health Category: Education, Health Funding Amount: $850,000 |
| Single Source: NCI National Clinical Trials Network - Network Radiotherapy and Imaging Core Services Center (U24 Clinical Trial Not Allowed) Apply for RFA CA 24 034 Funding Number: RFA CA 24 034 Agency: National Institutes of Health Category: Education, Health Funding Amount: $8,140,000 |
| Epidemiologic Research on Emerging Risk Factors and Liver Cancer Susceptibility (R21 Clinical Trial Not Allowed) Apply for PA 25 123 Funding Number: PA 25 123 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PAR 25 043", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
